BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38426412)

  • 21. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
    Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial neoplasia coincides with exacerbated injury and fibrotic response in the lungs of Gprc5a-knockout mice following silica exposure.
    Wang X; Xu D; Liao Y; Zhong S; Song H; Sun B; Zhou BP; Deng J; Han B
    Oncotarget; 2015 Nov; 6(37):39578-93. PubMed ID: 26447616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
    Sharma P; Singh N; Sharma S
    J Gene Med; 2023 Jan; 25(1):e3460. PubMed ID: 36314103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cells.
    Zhang L; Li Y; Hu C; Chen Y; Chen Z; Chen ZS; Zhang JY; Fang S
    Mol Cancer; 2022 Apr; 21(1):103. PubMed ID: 35459184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sildenafil is not a useful modulator of ABCB1 and ABCG2 mediated drug resistance in vivo.
    Lin F; Hoogendijk L; Buil L; Beijnen JH; van Tellingen O
    Eur J Cancer; 2013 May; 49(8):2059-64. PubMed ID: 23422148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. circ_0002060 Enhances Doxorubicin Resistance in Osteosarcoma by Regulating the miR-198/ABCB1 Axis.
    Ji Y; Liu J; Zhu W; Ji J
    Cancer Biother Radiopharm; 2023 Nov; 38(9):585-595. PubMed ID: 33351694
    [No Abstract]   [Full Text] [Related]  

  • 27. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
    Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
    J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo.
    Yang L; Li M; Wang F; Zhen C; Luo M; Fang X; Zhang H; Zhang J; Li Q; Fu L
    Cell Physiol Biochem; 2018; 46(6):2487-2499. PubMed ID: 29742496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer.
    Liu B; Yang H; Pilarsky C; Weber GF
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of Chemoresistance by Mg
    Onuma S; Manabe A; Yoshino Y; Matsunaga T; Asai T; Ikari A
    Cells; 2021 May; 10(5):. PubMed ID: 34066059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhibitory effect of downregulating G protein-coupled receptor class C group 5 member A expression on lipopolysaccharide-induced inflammatory response in human gingival fibroblasts].
    Hu YH; Shang LL; Ge SH
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2024 Apr; 59(4):344-353. PubMed ID: 38548591
    [No Abstract]   [Full Text] [Related]  

  • 32. Lung cancer suppressor gene GPRC5A mediates p53 activity in non‑small cell lung cancer cells in vitro.
    Jin E; Wang W; Fang M; Wang L; Wu K; Zhang Y; Zhang S; Ma S
    Mol Med Rep; 2017 Nov; 16(5):6382-6388. PubMed ID: 28849235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gprc5a-deficiency confers susceptibility to endotoxin-induced acute lung injury via NF-κB pathway.
    Liao Y; Song H; Xu D; Jiao H; Yao F; Liu J; Wu Y; Zhong S; Yin H; Liu S; Wang X; Guo W; Sun B; Han B; Chin YE; Deng J
    Cell Cycle; 2015; 14(9):1403-12. PubMed ID: 25714996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography.
    Wanek T; Römermann K; Mairinger S; Stanek J; Sauberer M; Filip T; Traxl A; Kuntner C; Pahnke J; Bauer F; Erker T; Löscher W; Müller M; Langer O
    Mol Pharm; 2015 Sep; 12(9):3214-25. PubMed ID: 26202880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orphan G protein-coupled receptor GPRC5A modulates integrin β1-mediated epithelial cell adhesion.
    Bulanova DR; Akimov YA; Rokka A; Laajala TD; Aittokallio T; Kouvonen P; Pellinen T; Kuznetsov SG
    Cell Adh Migr; 2017 Sep; 11(5-6):434-446. PubMed ID: 27715394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo.
    Zhao XQ; Xie JD; Chen XG; Sim HM; Zhang X; Liang YJ; Singh S; Talele TT; Sun Y; Ambudkar SV; Chen ZS; Fu LW
    Mol Pharmacol; 2012 Jul; 82(1):47-58. PubMed ID: 22491935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer.
    Sawada Y; Kikugawa T; Iio H; Sakakibara I; Yoshida S; Ikedo A; Yanagihara Y; Saeki N; Győrffy B; Kishida T; Okubo Y; Nakamura Y; Miyagi Y; Saika T; Imai Y
    Int J Cancer; 2020 Mar; 146(5):1369-1382. PubMed ID: 31276604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.
    Vesel M; Rapp J; Feller D; Kiss E; Jaromi L; Meggyes M; Miskei G; Duga B; Smuk G; Laszlo T; Karner I; Pongracz JE
    Respir Res; 2017 Mar; 18(1):52. PubMed ID: 28340578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells.
    Guo C; Liu F; Qi J; Ma J; Lin S; Zhang C; Zhang Q; Zhang H; Lu R; Li X
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters.
    Mi YJ; Liang YJ; Huang HB; Zhao HY; Wu CP; Wang F; Tao LY; Zhang CZ; Dai CL; Tiwari AK; Ma XX; To KK; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2010 Oct; 70(20):7981-91. PubMed ID: 20876799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.